Scientists test custom cancer vaccine made from Patient's own tumor
Disease control
Recruiting now
This is an early, small study to see if a personalized cell-based vaccine is safe and can trigger an immune response in patients with recurrent ovarian cancer. Doctors will take a sample of the patient's tumor to create a custom vaccine, which is then injected back into the patie…
Phase: PHASE1 • Sponsor: PhotonPharma, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC